Showing results (71-80 of 82) with videos related to
Sort By:
Pageof 9
Cell Reports|November 6, 2024
An oral non-covalent non-peptidic inhibitor of SARS-CoV-2 Mpro ameliorates viral replication and pathogenesis in vivoNian E Zhou, Su Tang, Xuelin Bian, et al.Journal of Medicinal Chemistry|February 8, 2019
Boron-Pleuromutilins as Anti- Wolbachia Agents with Potential for Treatment of Onchocerciasis and Lymphatic FilariasisRobert T Jacobs, Christopher S Lunde, Yvonne R Freund, et al.Science (New York, N.Y.)|November 19, 2011
Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discoveryStephan Meister, David M Plouffe, Kelli L Kuhen, et al.Science (New York, N.Y.)|December 8, 2018
Open-source discovery of chemical leads for next-generation chemoprotective antimalarialsYevgeniya Antonova-Koch, Stephan Meister, Matthew Abraham, et al.Nature|November 29, 2013
Targeting Plasmodium PI(4)K to eliminate malariaCase W McNamara, Marcus Cs Lee, Chek Shik Lim, et al.Nature|July 31, 2025
SuFEx-based antitubercular compound irreversibly inhibits Pks13Inna V Krieger, Paridhi Sukheja, Baiyuan Yang, et al.Elife|September 30, 2025
A drug repurposing approach reveals targetable epigenetic pathways in <i>Plasmodium vivax</i> hypnozoitesSteven P Maher, Malina A Bakowski, Amélie Vantaux, et al.Science Translational Medicine|May 10, 2019
Discovery of short-course antiwolbachial quinazolines for elimination of filarial worm infectionsMalina A Bakowski, Roohollah Kazem Shiroodi, Renhe Liu, et al.Science (New York, N.Y.)|November 28, 2024
Systematic in vitro evolution in <i>Plasmodium falciparum</i> reveals key determinants of drug resistanceMadeline R Luth, Karla P Godinez-Macias, Daisy Chen, et al.NPJ Drug Discovery|March 11, 2025
Revisiting the <i>Plasmodium falciparum</i> druggable genome using predicted structures and data miningKarla P Godinez-Macias, Daisy Chen, J Lincoln Wallis, et al.Pageof 9